Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 63 most recent Form 4 transactions.
| Aug 21 | NMRA | Neumora Therapeutics, Inc. | SSELL | 21,055 | $1.60 | $33.6K | -100.0% | Open the original filing on SEC.gov |
| Aug 21 | NMRA | Neumora Therapeutics, Inc. | MEXER | 21,055 | $0.72 | $15.2K | — | Open the original filing on SEC.gov |
| Aug 21 | NMRA | Neumora Therapeutics, Inc. | SSELL | 20,553 | $1.59 | $32.8K | -29.7% | Open the original filing on SEC.gov |
| Aug 21 | NMRA | Neumora Therapeutics, Inc. | MEXER | 20,553 | $0.72 | $14.8K | +42.2% | Open the original filing on SEC.gov |
| Aug 20 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 200,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 20 | NMRA | Neumora Therapeutics, Inc. | MEXER◆ | 21,685 | — | — | — | Open the original filing on SEC.gov |
| Aug 20 | NMRA | Neumora Therapeutics, Inc. | MEXER◆ | 45,026 | — | — | — | Open the original filing on SEC.gov |
| Aug 20 | NMRA | Neumora Therapeutics, Inc. | MEXER◆ | 67,741 | — | — | — | Open the original filing on SEC.gov |
| Aug 20 | NMRA | Neumora Therapeutics, Inc. | SSELL | 66,711 | $1.51 | $101K | -100.0% | Open the original filing on SEC.gov |
| Aug 20 | NMRA | Neumora Therapeutics, Inc. | MEXER | 45,026 | $0.72 | $32.4K | +207.6% | Open the original filing on SEC.gov |
| Aug 20 | NMRA | Neumora Therapeutics, Inc. | MEXER | 21,685 | $0.72 | $15.6K | — | Open the original filing on SEC.gov |
| Aug 20 | NMRA | Neumora Therapeutics, Inc. | SSELL | 67,741 | $1.51 | $102.6K | -58.1% | Open the original filing on SEC.gov |
| Aug 20 | NMRA | Neumora Therapeutics, Inc. | MEXER | 67,741 | $0.72 | $48.8K | +139.0% | Open the original filing on SEC.gov |
| Aug 19 | NMRA | Neumora Therapeutics, Inc. | MEXER◆ | 30,918 | — | — | — | Open the original filing on SEC.gov |
| Aug 19 | NMRA | Neumora Therapeutics, Inc. | MEXER◆ | 17,732 | — | — | — | Open the original filing on SEC.gov |
| Aug 19 | NMRA | Neumora Therapeutics, Inc. | MEXER◆ | 13,268 | — | — | — | Open the original filing on SEC.gov |
| Aug 19 | NMRA | Neumora Therapeutics, Inc. | SSELL | 30,918 | $1.65 | $50.9K | -100.0% | Open the original filing on SEC.gov |
| Aug 19 | NMRA | Neumora Therapeutics, Inc. | MEXER | 30,918 | $0.72 | $22.3K | — | Open the original filing on SEC.gov |
| Aug 19 | NMRA | Neumora Therapeutics, Inc. | SSELL | 31,000 | $1.65 | $51K | -38.9% | Open the original filing on SEC.gov |
| Aug 19 | NMRA | Neumora Therapeutics, Inc. | MEXER | 17,732 | $0.72 | $12.8K | +28.6% | Open the original filing on SEC.gov |
| Aug 19 | NMRA | Neumora Therapeutics, Inc. | MEXER | 13,268 | $0.72 | $9.6K | +27.2% | Open the original filing on SEC.gov |
| Aug 18 | NMRA | Neumora Therapeutics, Inc. | MEXER◆ | 34,987 | — | — | — | Open the original filing on SEC.gov |
| Aug 18 | NMRA | Neumora Therapeutics, Inc. | MEXER◆ | 34,162 | — | — | — | Open the original filing on SEC.gov |
| Aug 18 | NMRA | Neumora Therapeutics, Inc. | SSELL | 34,987 | $1.59 | $55.5K | -100.0% | Open the original filing on SEC.gov |
| Aug 18 | NMRA | Neumora Therapeutics, Inc. | MEXER | 34,987 | $0.72 | $25.2K | — | Open the original filing on SEC.gov |
| Aug 18 | NMRA | Neumora Therapeutics, Inc. | SSELL | 34,162 | $1.58 | $54.1K | -41.2% | Open the original filing on SEC.gov |
| Aug 18 | NMRA | Neumora Therapeutics, Inc. | MEXER | 34,162 | $0.72 | $24.6K | +70.1% | Open the original filing on SEC.gov |
| Aug 17 | NMRA | Neumora Therapeutics, Inc. | MEXER◆ | 29,737 | — | — | — | Open the original filing on SEC.gov |
| Aug 17 | NMRA | Neumora Therapeutics, Inc. | MEXER◆ | 25,279 | — | — | — | Open the original filing on SEC.gov |
| Aug 17 | NMRA | Neumora Therapeutics, Inc. | MEXER◆ | 1 | — | — | — | Open the original filing on SEC.gov |
| Aug 17 | NMRA | Neumora Therapeutics, Inc. | MEXER◆ | 1,424 | — | — | — | Open the original filing on SEC.gov |
| Aug 17 | NMRA | Neumora Therapeutics, Inc. | MEXER◆ | 15,355 | — | — | — | Open the original filing on SEC.gov |
| Aug 17 | NMRA | Neumora Therapeutics, Inc. | MEXER◆ | 40,890 | — | — | — | Open the original filing on SEC.gov |
| Aug 17 | NMRA | Neumora Therapeutics, Inc. | SSELL | 55,016 | $1.50 | $82.8K | -100.0% | Open the original filing on SEC.gov |
| Aug 17 | NMRA | Neumora Therapeutics, Inc. | MEXER | 29,737 | $0.72 | $21.4K | +117.6% | Open the original filing on SEC.gov |
| Aug 17 | NMRA | Neumora Therapeutics, Inc. | MEXER | 25,279 | $0.72 | $18.2K | — | Open the original filing on SEC.gov |
| Aug 17 | NMRA | Neumora Therapeutics, Inc. | SSELL | 34,020 | $1.49 | $50.5K | -41.1% | Open the original filing on SEC.gov |
| Aug 17 | NMRA | Neumora Therapeutics, Inc. | SSELL | 57,670 | $1.51 | $86.8K | -41.1% | Open the original filing on SEC.gov |
| Aug 17 | NMRA | Neumora Therapeutics, Inc. | MEXER | 1 | $0.72 | $1 | 0.0% | Open the original filing on SEC.gov |
| Aug 17 | NMRA | Neumora Therapeutics, Inc. | MEXER | 1,424 | $0.72 | $1K | +1.0% | Open the original filing on SEC.gov |
| Aug 17 | NMRA | Neumora Therapeutics, Inc. | MEXER | 15,355 | $0.72 | $11.1K | +12.4% | Open the original filing on SEC.gov |
| Aug 17 | NMRA | Neumora Therapeutics, Inc. | MEXER | 40,890 | $0.72 | $29.4K | +49.4% | Open the original filing on SEC.gov |
| Feb 17 | NMRA | Neumora Therapeutics, Inc. | SSELL | 6,165 | $3.56 | $21.9K | -6.9% | Open the original filing on SEC.gov |
| Jan 8 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 750,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 11, 2025 | NMRA | Neumora Therapeutics, Inc. | SSELL◷ | 114,703 | $2.68 | $307K | -100.0% | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 1M | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 195,000 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 29,737 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 72,221 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 136,210 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 207,901 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 137,538 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 40,890 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 1M | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 195,000 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 29,737 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 72,221 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 136,210 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 207,901 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 137,538 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 40,890 | — | — | — | Open the original filing on SEC.gov |